Grimes & Company’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-489
Closed -$232K 458
2026
Q1
$232K Sell
489
-3
-0.6% -$1.51K 0.01% 397
2025
Q4
$230K Buy
492
+7
+1% +$3.25K 0.01% 422
2025
Q3
$207K Buy
+485
New +$188K 0.01% 435

Other funds holding HCA

Grimes & Company's HCA Position: Q2 2026 in Review

Grimes & Company sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 489 shares — an estimated $232K sold.

Grimes & Company first reported a position in HCA in Q3 2025 and held it in 3 quarters. The position peaked at $232K in Q1 2026. 549 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Grimes & Company reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Grimes & Company sold 489 HCA Healthcare shares in Q2 2026, an estimated $232K.
  • Grimes & Company first reported a position in HCA Healthcare in Q3 2025 and held it in 3 quarters.
  • Grimes & Company's HCA Healthcare position peaked at $232K in Q1 2026.
  • 549 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.